tiprankstipranks
Trending News
More News >

Clearside Biomedical reports Q1 EPS (11c), consensus (11c)

Reports Q1 revenue $2.3M, consensus $198K. The increase in revenue was primarily attributable to license fees from partners in Q1 of 2025, including $1.5M in milestones from Arctic Vision and $0.8M in other revenue for training, services and the sales of SCS Microinjector kits to licensees. As of March 31, Clearside’s cash and cash equivalents totaled $13.6M. The company believes it will have sufficient resources to fund its planned operations into Q4 of 2025.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue